<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02483364</url>
  </required_header>
  <id_info>
    <org_study_id>STEMQUIRI/12ES01</org_study_id>
    <nct_id>NCT02483364</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Assess the Effect of HC-SVT-1001 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones</brief_title>
  <official_title>A Phase II Clinical Trial to Assess the Effect of HC-SVT-1001 (Autologous Fat Stem Adult Mesenchymal Cells Expanded and Combined With a Tricalcium Phosphate Biomaterial) in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Salvat</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Salvat</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose os this study is to evaluate the safety and effectiveness of HC-SVT-1001 in the
      surgical treatment of atrophic nonunion in long bones.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Cell therapy</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of HC-SVT-1001 in the surgical treatment of atrophic nonunion in long bones by recording of adverse events.</measure>
    <time_frame>Up to 24 months after surgery.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness by mean of radiological methods on the appearance of signs of osseous setting formation.</measure>
    <time_frame>Within 6 months after surgery.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparative statistical analysis</measure>
    <time_frame>Up to 24 months after surgery.</time_frame>
    <description>Comparative statistical analysis between the 10 patients of this study and the data of 14 consecutive cases of refractory nonunion of long bones that have been treated since Sept-2009 with 40x10(6) autologous fat stem adult mesenchymal and under AEMPS compassionate use requirements.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Pseudoarthrosis</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HC-SVT-1001. Intraosseous use. 3x10(6) cells/cm3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>HC-SVT-1001</intervention_name>
    <description>A single application in the context of a single surgical intervention.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of either sex between 18 and 65 years of age (both inclusive).

          -  Diagnosis of atrophic pseudoarthrosis of long bones confirmed radiographically.

        Exclusion Criteria:

          -  Present infection (infection signs should not be evidenced).

          -  Other lesions which interfere with the body weight load.

          -  Open pseudoarthrosis (at the time of inclusion).

          -  Congenital bone diseases (hypophosphatemia), metabolic bone disease associated with
             primary or secondary hypoparathyroidism.

          -  Other conditions or circumstances that compromise the study participation according to
             medical criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enrique Jimenez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Laboratorios Salvat</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Enrique Jiménez, MD</last_name>
    <phone>+34933946400</phone>
    <phone_ext>470</phone_ext>
    <email>clinicaltrials@salvatbiotech.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Laboratorios SALVAT, S.A.</name>
      <address>
        <city>Esplugues de Llobregat</city>
        <state>Barcelone</state>
        <zip>08950</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrique Jiménez, MD</last_name>
      <phone>+34933946400</phone>
      <phone_ext>470</phone_ext>
      <email>clinicaltrials@salvatbiotech.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2015</study_first_submitted>
  <study_first_submitted_qc>June 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2015</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pseudarthrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

